Pancreatic Cancer Research

ResearcherFujian Medical UniversityActive in the last 2 years

Feng Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7420-2498; OpenAlex author ID A5027593184, A5122211131. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 3 papers · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 9

  1. Prostaglandin E2-driven dedifferentiation of Schwann cells leads to perineural invasion in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41392-026-02648-x↗
  2. PIEZO1 enhances pancreatic cancer neurotropism. Last author DOI 10.1186/s12935-026-04244-z↗
  3. Methylation of CALCA and CALCB in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1155/2021/2088345↗
  4. DDIT4 Novel Mutations in Pancreatic Cancer. Last author DOI 10.1155/2021/6674404↗
  5. DDIT4 is involved in PPAR-γ mediated Fatty Acid intake to promote the Proliferation of Pancreatic Cancer First author DOI 10.21203/rs.3.rs-157763/v1↗
  6. PRSS1 mutation: a possible pathomechanism of pancreatic carcinogenesis and pancreatic cancer. Last author DOI 10.1186/s10020-019-0111-4↗
  7. Pancreatic cancer and associated exosomes. First author DOI 10.3233/cbm-170258↗
  8. PRSS1 mutations and the proteinase/antiproteinase imbalance in the pathogenesis of pancreatic cancer. Co-author DOI 10.1007/s13277-015-3982-1↗
  9. The -409 C/T genotype of PRSS1 protects against pancreatic cancer in the Han Chinese population. Last author DOI 10.1007/s10620-011-1893-6↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qicai Liu · 9 shared papers, 2012–2026 · strength 1.30
  2. Ling Wang · 2 shared papers, 2026 · strength 0.59
  3. Shangeng Weng · 2 shared papers, 2026 · strength 0.59
  4. Fadian Ding · 3 shared papers, 2021 · strength 0.39
  5. Jinhong Li · 1 shared paper, 2026 · strength 0.32
  6. Jiahong Dong · 1 shared paper, 2026 · strength 0.27
  7. Youting Chen · 2 shared papers, 2021 · strength 0.27
  8. Jingwen Wang · 2 shared papers, 2019–2021 · strength 0.24
  9. Xinhua Lin · 2 shared papers, 2012–2019 · strength 0.15
  10. Shuyu Zhang · 1 shared paper, 2021 · strength 0.13
  11. Chengfei Zhao · 1 shared paper, 2017 · strength 0.10
  12. Qingliang He · 1 shared paper, 2016 · strength 0.07
  13. Qiang Yi · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.